Gland Pharma informs about receipt of establishment inspection report from US FDA

08 Nov 2023 Evaluate
Further to intimation dated July 28, 2023; Gland Pharma has informed that following the ‘Good Manufacturing Practice (GMP) Inspection’ by US FDA at the Company’s VSEZ Sterile Oncology Facility at Visakhapatnam between 20th July, 2023 and 28th July, 2023; the Company has received Establishment Inspection Report (EIR) from the US FDA indicating closure of the inspection.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1653.35 3.95 (0.24%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×